Histoplasma capsulatum at the host-pathogen interface
- PMID: 18672088
- PMCID: PMC2586805
- DOI: 10.1016/j.micinf.2008.07.011
Histoplasma capsulatum at the host-pathogen interface
Abstract
Histoplasma capsulatum is the most common cause of invasive fungal pulmonary disease worldwide. The interaction of H. capsulatum with a host is a complex, dynamic process. Severe disease most commonly occurs in individuals with compromised immunity, and the increasing utilization of immunomodulators in medicine has revealed significant risks for reactivation disease in patients with latent histoplasmosis. Fortunately, there are well developed molecular tools and excellent animal models for studying H. capsulatum virulence and numerous recent advances have been made regarding the pathogenesis of this fungus that will improve our capacity to combat disease.
Conflict of interest statement
Similar articles
-
Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.J Microbiol. 2016 Mar;54(3):265-76. doi: 10.1007/s12275-016-6044-5. Epub 2016 Feb 27. J Microbiol. 2016. PMID: 26920886 Review.
-
Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment.Fungal Genet Biol. 2002 Mar;35(2):81-97. doi: 10.1006/fgbi.2001.1311. Fungal Genet Biol. 2002. PMID: 11848673 Review.
-
[Dimorphism and pathogenesis of Histoplasma capsulatum].Rev Argent Microbiol. 2006 Oct-Dec;38(4):235-42. Rev Argent Microbiol. 2006. PMID: 17370580 Review. Spanish.
-
Histoplasma Capsulatum: Mechanisms for Pathogenesis.Curr Top Microbiol Immunol. 2019;422:157-191. doi: 10.1007/82_2018_114. Curr Top Microbiol Immunol. 2019. PMID: 30043340 Free PMC article. Review.
-
Histoplasma capsulatum and Caenorhabditis elegans: a simple nematode model for an innate immune response to fungal infection.Med Mycol. 2009 Dec;47(8):808-13. doi: 10.3109/13693780802660532. Med Mycol. 2009. PMID: 20028234
Cited by
-
Innate antifungal immunity: the key role of phagocytes.Annu Rev Immunol. 2011;29:1-21. doi: 10.1146/annurev-immunol-030409-101229. Annu Rev Immunol. 2011. PMID: 20936972 Free PMC article. Review.
-
Concentration-dependent protein loading of extracellular vesicles released by Histoplasma capsulatum after antibody treatment and its modulatory action upon macrophages.Sci Rep. 2018 May 23;8(1):8065. doi: 10.1038/s41598-018-25665-5. Sci Rep. 2018. PMID: 29795301 Free PMC article.
-
Pulmonary Histoplasmosis: A Clinical Update.J Fungi (Basel). 2023 Feb 10;9(2):236. doi: 10.3390/jof9020236. J Fungi (Basel). 2023. PMID: 36836350 Free PMC article. Review.
-
Cutaneous histoplasmosis disclosing an HIV-infection.An Bras Dermatol. 2013 May-Jun;88(3):420-3. doi: 10.1590/abd1806-4841.20131812. An Bras Dermatol. 2013. PMID: 23793220 Free PMC article.
-
Changes in membrane fluid state and heat shock response cause attenuation of virulence.J Bacteriol. 2010 Apr;192(7):1999-2005. doi: 10.1128/JB.00990-09. Epub 2010 Feb 5. J Bacteriol. 2010. PMID: 20139193 Free PMC article.
References
-
- Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: a review. Semin Respir Infect. 2001;16:109–118. - PubMed
-
- Kwon-Chung KJ, Bennett JE. Histoplasmosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical Mycology. Lea and Febiger; Philadelphia: 1992. pp. 464–513.
-
- Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol. 1996;7:7–18. - PubMed
-
- Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel F, Huerre M, Dromer F, Dupont B, Lortholary O. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. Aids. 2006;20:119–121. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical